VTAL — Justera Health Income Statement
0.000.00%
Last trade - 00:00
- CA$0.80m
- CA$0.86m
- CA$14.69m
- 45
- 54
- 10
- 29
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 13 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 21.2 | 14.7 |
Cost of Revenue | |||||
Gross Profit | — | — | — | 2.7 | 2.58 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.105 | 0.052 | 0.072 | 31.4 | 19.9 |
Operating Profit | -0.105 | -0.052 | -0.072 | -10.2 | -5.25 |
Net Income Before Taxes | -0.105 | -0.052 | -0.072 | -10.2 | -5.25 |
Net Income After Taxes | -0.105 | -0.052 | -0.072 | -10.2 | -5.25 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.105 | -0.052 | -0.072 | -10.2 | -5.25 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.105 | -0.052 | -0.072 | -10.2 | -5.25 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.003 | -0.001 | -0.002 | -0.118 | -0.045 |
Dividends per Share |